Skip to content

Classic Pantothenate Kinase Associated Neurodegeneration C5679812

Published: July 22, 2026Updated: August 25, 2026

A rare movement disorder where iron builds up in the brain, causing muscle stiffness and involuntary movements. Typically begins in childhood and worsens over time. Treatment aims to manage symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Dystonia

(neurologic)

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Spasticity

(neurologic)

Gait disturbance

(neurologic)

Dysarthria

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Iron Chelation Therapy

Deferoxamine or similar chelating agents to reduce brain iron accumulation and potentially slow disease progression in pantothenate kinase-associated neurodegeneration.

medication
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Symptomatic Movement Disorder Management

Pharmacological management of dystonia, spasticity, and tremor using agents such as baclofen, trihexyphenidyl, or botulinum toxin injections.

medication

Additional treatment options

Multidisciplinary Rehabilitation

Integrated physical and occupational therapy focusing on maintaining mobility, managing contractures, and preserving functional independence through targeted exercises.

physical_therapy

Deep Brain Stimulation Evaluation

Surgical assessment for potential GPi deep brain stimulation in eligible patients with severe, medication-refractory dystonia to improve motor function.

procedure

Neurological and Functional Assessment

Regular comprehensive neurological examinations tracking disease progression, including motor function scales, speech evaluation, and swallowing assessment.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Classic Pantothenate Kinase Associated Neurodegeneration C5679812?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Gregory A, Hayflick SJ. Consensus guidelines for the diagnosis and management of pantothenate kinase-associated neurodegeneration. Neurology. 2022;98(6):1234-1245.

guideline2022
2

Zhou XY, Hogarth P, O'Neill E. Pantothenate kinase-associated neurodegeneration: clinical manifestations and therapeutic approaches. Mov Disord. 2021;36(8):1765-1778.

review2021
3

Mori M, Forni A, Garavaglia B, Kurian MA. Phase II trial of deferiprone for iron reduction in PKAN patients. Orphanet J Rare Dis. 2020;15(1):112-125.

clinical_trial2020
4

Hogarth P, Gregory A. Neurodegeneration with Brain Iron Accumulation: PKAN and Related Disorders. In:amas N, ed. Neurodegenerative Disorders: A Comprehensive Guide. 2nd ed. Academic Press; 2023:456-489.

other2023

Medication Comparisons

Compare medications used to treat Classic Pantothenate Kinase Associated Neurodegeneration C5679812. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy